Our Network of Board-Certified Providers
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
People living in the Hopkins-Middle East area of Baltimore, Maryland can access FDA-approved GLP-1 receptor agonist medications through a secure online telehealth consultation. Our network of MD-licensed physicians provides personalized weight management and metabolic health treatment for patients across Baltimore City County.
GLP-1 medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are prescribed by board-certified doctors who understand the healthcare needs of Baltimore residents. The complete process — from assessment to medication delivery — happens online.[1][2]
Medically reviewed by
Dr. Sarah Mitchell, MD, ABOM
Board-Certified in Obesity Medicine • Last reviewed: June 4, 2026
Semaglutide is marketed as Ozempic for type 2 diabetes management and Wegovy for chronic weight loss in adults with obesity or overweight. Licensed physicians design individualized titration schedules — escalating dose over 16–20 weeks — to maximize weight reduction while minimizing gastrointestinal side effects.
Tirzepatide simultaneously activates GLP-1 and GIP receptors, producing additive metabolic effects beyond those of single-agonist GLP-1 therapies. Mounjaro (type 2 diabetes) and Zepbound (obesity) require physician expertise in dual-receptor pharmacology and careful patient selection to optimize outcomes.
Landmark randomized controlled trials in the New England Journal of Medicine establish the efficacy profile of FDA-approved GLP-1 medications available to Hopkins-Middle East, Baltimore residents:
Telehealth prescribing of GLP-1 receptor agonists in Maryland is conducted by board-certified, MD-licensed physicians through HIPAA-compliant platforms. GLP-1 medications are not DEA-scheduled controlled substances and may be prescribed via telehealth after a valid clinical evaluation.
Getting prescribed GLP-1 medication from Hopkins-Middle East is fully online. No travel across Baltimore required — everything is handled through our secure telehealth platform from your home.
Complete a brief health questionnaire from your home in Hopkins-Middle East. This covers your medical history, current medications, BMI, and weight management goals. Takes 2-3 minutes to complete.
A MD-licensed physician reviews your health profile and conducts a personalized telehealth consultation. They recommend the most appropriate GLP-1 medication for your individual needs and discuss expected outcomes.
Once prescribed, your GLP-1 medication ships from a licensed US pharmacy directly to your Hopkins-Middle East address. Most patients in Baltimore receive their medication within 3-5 business days in secure, temperature-controlled packaging.
Our telehealth providers serve all neighborhoods in Baltimore and surrounding areas.
Explore GLP-1 telehealth services across every neighborhood in Baltimore, MD.
Also serving residents of cities near Baltimore.
Explore GLP-1 telehealth services in the largest cities across Maryland.
Licensed GLP-1 telehealth physicians serve neighborhoods across all major US cities, providing the same clinical-grade care available at specialty obesity medicine centers.
Local weight loss and GLP-1 providers serving the Hopkins-Middle East, Baltimore area, based on Google Business listings.
516 N Charles St, Baltimore, MD 21201
5/5 ★ (9 reviews)
7112 Darlington Dr, Parkville, MD 21234
5/5 ★ (109 reviews)
617 Stemmers Run Rd F, Baltimore, MD 21221
4.9/5 ★ (19 reviews)
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
Yes. All residents of Hopkins-Middle East and the greater Baltimore, Maryland area can access GLP-1 telehealth through our MD-licensed providers. The entire process is online.
After physician approval, most patients in the Hopkins-Middle East area of Baltimore receive their GLP-1 medication within 3-5 business days via direct home delivery from a licensed US pharmacy.
No. Everything is handled through secure telehealth — no clinic or pharmacy trips required in Baltimore. Your consultation, prescription, and delivery are all managed online from your home.
Providers can prescribe all FDA-approved GLP-1 medications to eligible Baltimore City County residents, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda).
Yes. All prescriptions are issued by board-certified, MD-licensed physicians through HIPAA-compliant telehealth platforms. Medications are dispensed exclusively from verified US pharmacies.
Black Box Warning: In rodent studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and injection site reactions. These typically diminish as dosage is gradually escalated.
Serious side effects may include pancreatitis, gallbladder problems, kidney injury, hypoglycemia (with insulin), and allergic reactions. Consult your healthcare provider immediately if you experience severe symptoms.
Contraindications: History of medullary thyroid carcinoma, MEN 2, pancreatitis, pregnancy or breastfeeding, severe gastrointestinal disease. This is not a complete list — always discuss your full medical history with your physician.
Clinical References:
